89 FR 245 pgs. 104195-104196 - National Cancer Institute; Notice of Closed Meetings
Type: NOTICEVolume: 89Number: 245Pages: 104195 - 104196
Pages: 104195, 104196FR document: [FR Doc. 2024-30326 Filed 12-19-24; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis Panel; Diet, Lipid Metabolism, and Cancer.
Date: January 30, 2025.
Time: 9:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W248, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Shree Ram Singh, Ph.D., Scientific Review Officer ,Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W248 Rockville, Maryland 20850, 240-672-6175, singhshr@mail.nih.gov .
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP-5: NCI Clinical and Translational Cancer Research.
Date: February 12, 2025.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W248, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Shree Ram Singh, Ph.D., Scientific Review Officer ,Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W248 Rockville, Maryland 20850, 240-672-6175, singhshr@mail.nih.gov .
Name of Committee: National Cancer Institute Special Emphasis Panel; RNA Modifications Driving Oncogenesis (RNAMoDO; U01 Clinical Trial Not Allowed).
Date: February 14, 2025.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications
Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W260, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Robert F. Gahl, Ph.D., Scientific Review Officer, Special Review Branch ,Division of Extramural Activities, National Cancer Institute, NIH, 9606 Medical Center Drive, Room 7W260 Rockville, Maryland 20850, 240-276-7869, robert.gahl@nih.gov .
Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Prevention Clinical Trials Network-Sites and Data Management.
Date: February 14, 2025.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W108, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343, schweinfestcw@mail.nih.gov .
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP-12: NCI Clinical and Translational Cancer Research.
Date: February 14, 2025.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W244, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Amr M. Ghaleb, Ph.D., Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W244, Rockville, Maryland 20850, 240-276-6611, amr.ghaleb@nih.gov
Name of Committee: National Cancer Institute Initial Review Group; Career Development Study Section (J).
Date: February 19-20, 2025.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W624, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W624, Rockville, Maryland 20850, 240-276-6132, tushar.deb@nih.gov .
Name of Committee: National Cancer Institute Special Emphasis Panel; SBIR Concept Award TEP.
Date: February 21, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W608, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W608, Rockville, Maryland 20850, 240-276-5856, nadeem.khan@nih.gov .
[top]
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP-8: NCI Clinical and Translational Cancer Research.
Date: February 25, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W110, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Priya Srinivasan, Ph.D., Scientific Review Officer, Resource and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W110, Rockville, Maryland 20850, 240-276-5619, priya.srinivasan@nih.gov .
Name of Committee: National Cancer Institute Special Emphasis Panel; TEP-1: SBIR Contract Review Meeting.
Date: February 26, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W624, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Ombretta Salvucci, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W264, Rockville, Maryland 20850, 240-276-7286, salvucco@mail.nih.gov .
Name of Committee: National Cancer Institute Special Emphasis Panel; TEP-3: SBIR Contract Review.
Date: February 27, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W106, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W106, Rockville, Maryland 20850, 240-276-7975, chufanee@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP-6: NCI Clinical and Translational Cancer Research.
Date: February 28, 2025.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W260, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Robert F. Gahl, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9606 Medical Center Drive, Room 7W260, Rockville, Maryland 20850, 240-276-7869, robert.gahl@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP-1: NCI Clinical and Translational Cancer Research.
Date: March 6, 2025.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W108, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343, schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Prevention and Control Clinical Trials Planning.
Date: March 6, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W608, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W608, Rockville, Maryland 20850, 240-276-5856, nadeem.khan@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; TEP-9: SBIR Contract Review Meeting.
Date: March 7, 2025.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W612, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Prashant Sharma, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W612, Rockville, Maryland 20850, 240-275-6351, prashant.sharma@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP-13: NCI Clinical and Translational Cancer Research.
Date: March 13, 2025.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W618, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: E. Tian, Ph.D., Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W618, Rockville, Maryland 20850, 240-276-6611, tiane@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; TEP-10: SBIR Contract Review Meeting.
Date: March 14, 2025.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract proposals.
Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W238, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W238, Rockville, Maryland 20850, 240-276-7755, byeong-chel.lee@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; Metastasis Research Network (U01).
Date: March 21, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W120, Rockville, Maryland 20850.
Meeting Format: Virtual Meeting.
Contact Person: Majed M. Hamawy, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive Room 7W120, Rockville, Maryland 20850, 240-276-6457, mh101v@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)
Dated: December 16, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-30326 Filed 12-19-24; 8:45 am]
BILLING CODE 4140-01-P